文献速递艾滋病与性传播感染

MSM启动DTG/ABC/3TC后直肠与精液HIV-1 RNA衰减至病毒学抑制

Rectal and seminal HIV-1 RNA decay towards virological suppression in infected MSM initiating dolutegravir/abacavir/lamivudine.
PubMed 文献 · J Antimicrob Chemother · 2020-01-01

该纵向队列研究纳入12名初治HIV阳性MSM,启动多替拉韦/阿巴卡韦/拉米夫定后,血浆HIV-1 RNA在20周均抑制,但直肠和精液分别有50%和42%可检出。基线血浆病毒载量与直肠抑制时间相关(P=0.025),部分患者病毒脱落持续至1年。

要点

  • DTG/ABC/3TC启动后直肠和精液病毒衰减慢于血浆。
  • 20周时血浆均抑制,但直肠和精液分别50%和42%可检出。
  • 基线血浆病毒载量影响直肠抑制时间(P=0.025)。

核心结论

  • 启动DTG/ABC/3TC后直肠黏膜和精液中的HIV-1 RNA衰减速度慢于血浆。
  • 约半数患者在20周时直肠和生殖道分泌物中仍可检出HIV-1 RNA,部分患者病毒脱落持续至1年。

研究设计与样本

  • 纵向队列研究,纳入12名初治HIV阳性MSM,中位年龄36(IQR 33-40)岁,基线CD4+计数449(IQR 411-503)cells/mm3。
  • 在ART启动第1天(基线)及每4周至第20周(所有参与者)和第64周(12人中6人)定量直肠黏膜和精浆样本中的HIV-1 RNA。

主要发现

  • 基线时所有血浆和精液样本及10/12直肠样本可检出HIV-1 RNA。
  • 第20周所有参与者血浆病毒学抑制,但精液和直肠样本分别有42%和50%可检出HIV-1 RNA。
  • 第64周6人中1人精液和1人直肠样本可检出HIV-1 RNA。
  • 基线精液和直肠HIV-1 RNA水平与储库病毒脱落(HIV-1 RNA >200 copies/mL或copies/swab)相关。
  • 基线血浆病毒载量与直肠HIV-1 RNA <200 copies/swab的时间显著相关(P=0.025)。

临床怎么用

  • 临床应知晓DTG/ABC/3TC启动后直肠和精液病毒抑制延迟,20周时仍可能具传染性。
  • 对MSM患者进行性传播风险咨询时,需考虑生殖道储库病毒脱落可能持续至1年。

局限性

  • 样本量小(12人),仅6人随访至64周。
  • 未设对照组,随访时间有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The time at which the protective effect of starting ART is achieved in male rectal and genital reservoirs is not clearly established. OBJECTIVES: To quantify HIV-1 RNA decay towards virological suppression in rectal mucosa and semen in MSM starting dolutegravir/abacavir/lamivudine (DTG/ABC/3TC). METHODS: A longitudinal cohort study of ART-naive HIV-positive MSM was performed. HIV-1 RNA was quantified in rectal mucosa and seminal plasma samples at day 1 of ART initiation (baseline) and every 4 weeks until week 20 (w20; all participants) and week 64 (w64; 6 of 12 participants). RESULTS: Twelve MSM, with median (IQR) age 36 (33-40) years and baseline CD4+ count 449 (411-503) cells/mm3, were included. At baseline, HIV-1 RNA was detectable in all plasma and seminal samples and 10/12 rectal samples. All participants achieved plasma virological suppression by w20, whereas HIV-1 RNA was detectable in 42% and 50% of seminal and rectal samples, respectively. At w64, HIV-1 RNA was detectable in 1/6 seminal and 1/6 rectal samples. A relationship of baseline seminal and rectal HIV-1 RNA levels with viral shedding in reservoirs (HIV-1 RNA >200 copies/mL or copies/swab) was found. In addition, a significant association of baseline plasma viral load with time to rectal HIV-1 RNA <200 copies/swab was found (P=0.025). CONCLUSIONS: Viral decay after initiating DTG/ABC/3TC is slower in rectal mucosa and semen than in plasma. Approximately half of patients achieved undetectable HIV-1 RNA levels in rectal and genital secretions at w20 and in some patients viral shedding persisted for up to 1 year. Initial plasma viral load influences time to rectal suppression.

来源:J Antimicrob Chemother,查看原文。版权归原作者所有。

引用

  1. Fernández-González M, García JA, Padilla S, et al. Rectal and seminal HIV-1 RNA decay towards virological suppression in infected MSM initiating dolutegravir/abacavir/lamivudine. J Antimicrob Chemother. 2020. PMID: 31769846. doi:10.1093/jac/dkz482

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。